content: <HTML>
  <HEAD>
  <TITLE></TITLE>
  </HEAD>
  <BODY>
  
  
  <P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;SECURITIES
  AND EXCHANGE COMMISSION</P>
  
  <P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">Washington, D.C. 20549</P>
  
  <P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
  
  <P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">FORM 8-K</P>
  
  <P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
  
  <P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">CURRENT REPORT</P>
  
  <P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
  
  <P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">Pursuant to Section 13 or 15(d)</P>
  
  <P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">of the Securities Exchange Act of 1934</P>
  
  <P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
  
  <P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">Date of Report (date of earliest event
  reported):</P>
  
  <P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">March 9, 2015</P>
  
  <P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in">&nbsp;&nbsp;</P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="background-color: white">
      <TD COLSPAN="5" STYLE="border-bottom: black 1pt solid; padding-bottom: 10pt; text-align: center; line-height: 115%"><B>EVENT
      CARDIO GROUP INC.</B></TD></TR>
  <TR STYLE="background-color: white">
      <TD COLSPAN="5" STYLE="padding-bottom: 10pt; text-align: center; line-height: 115%">(Exact name of registrant as specified
      in its charter)</TD></TR>
  <TR STYLE="vertical-align: bottom">
      <TD STYLE="width: 30%; border-bottom: black 1pt solid; padding-bottom: 10pt; text-align: center; line-height: 115%"><B>Nevada</B></TD>
      <TD STYLE="width: 5%; padding-bottom: 10pt; text-align: center; line-height: 115%">&nbsp;</TD>
      <TD STYLE="width: 30%; border-bottom: black 1pt solid; padding-bottom: 10pt; text-align: center; line-height: 115%"><B>0-52518</B></TD>
      <TD STYLE="width: 5%; padding-bottom: 10pt; text-align: center; line-height: 115%">&nbsp;</TD>
      <TD STYLE="width: 30%; border-bottom: black 1pt solid; padding-bottom: 10pt; text-align: center; line-height: 115%"><B>20-8051714</B></TD></TR>
  <TR>
      <TD STYLE="padding-bottom: 10pt; text-align: center; line-height: 115%">(State or other jurisdiction of Incorporation)</TD>
      <TD STYLE="vertical-align: top; padding-bottom: 10pt; text-align: center; line-height: 115%">&nbsp;</TD>
      <TD STYLE="padding-bottom: 10pt; text-align: center; line-height: 115%">(Commission File Number)</TD>
      <TD STYLE="vertical-align: top; padding-bottom: 10pt; text-align: center; line-height: 115%">&nbsp;</TD>
      <TD STYLE="padding-bottom: 10pt; text-align: center; line-height: 115%">(I.R.S. Employer Identification No.)</TD></TR>
  </TABLE>
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in">&nbsp;</P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: bottom">
      <TD STYLE="width: 45%; border-bottom: black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>2798 Thamesgate Dr.</B></P>
          <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Mississauga, Ontario, Canada</B></P></TD>
      <TD STYLE="width: 10%; padding-bottom: 10pt; text-align: center; line-height: 115%">&nbsp;</TD>
      <TD STYLE="width: 45%; border-bottom: black 1pt solid; padding-bottom: 10pt; text-align: center; line-height: 115%"><B>L4T
      4E8</B></TD></TR>
  </TABLE>
  <P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0pt; text-align: justify">Check the appropriate box below if the
  Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions
  (see General Instruction A.2. below):</P>
  
  <P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
  
  <TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><TR STYLE="vertical-align: top; text-align: justify">
  <TD STYLE="width: 15pt; text-align: right">&bull;</TD><TD STYLE="width: 5pt"></TD><TD STYLE="text-align: justify">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</TD>
  </TR></TABLE>
  
  <P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
  
  <TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><TR STYLE="vertical-align: top; text-align: justify">
  <TD STYLE="width: 15pt; text-align: right">&bull;</TD><TD STYLE="width: 5pt"></TD><TD STYLE="text-align: justify">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17&nbsp;&nbsp;&nbsp;CFR
  240.14a-12)</TD>
  </TR></TABLE>
  
  <P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>
  
  <TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><TR STYLE="vertical-align: top; text-align: justify">
  <TD STYLE="width: 15pt; text-align: right">&bull;</TD><TD STYLE="width: 5pt"></TD><TD STYLE="text-align: justify">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17
  CFR 240.14d-2(b))</TD>
  </TR></TABLE>
  
  <P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>
  
  <TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><TR STYLE="vertical-align: top; text-align: justify">
  <TD STYLE="width: 15pt; text-align: right">&bull;</TD><TD STYLE="width: 5pt"></TD><TD STYLE="text-align: justify">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17
  CFR 240.13e-4(c))</TD>
  </TR></TABLE>
  
  <P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
  
  <P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"></P>
  
  
  <!-- Field: Page; Sequence: 1 -->
      <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
      <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
      <!-- Field: /Page -->
  
  <P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"><B>Item 3.02 Sale of Unregistered Securities.</B></P>
  
  <P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
  
  <P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0pt; text-align: justify">On March 5, 2015, the Company received
  $200,000 from Medpac Asia Pacific PTY Ltd. in respect of the initial $500,000 due pursuant to the Regulation S Subscription Agreement
  and Investment Representation received by the Company from Medpac. The Subscription Agreement provides for an investment of $500,000
  by MedPpac for which it is to receive an 8% Convertible Promissory Note in the principal amount of $500,000 (the &#8220;Note&#8221;).
  Interest accrued on the Note is payable annually on January 31, commencing January 31, 2016. The principal amount of the Note,
  together with accrued interest is payable on January 31, 2018. The principal and any interest accrued and not paid in cash, is
  convertible into common shares of the Company at a conversion price of $0.15 per share. The Note may be prepaid at any time upon
  ten days notice to the Holder, except that if the Note is prepaid when the common stock of the Company is trading at less than
  $0.15 per share, in addition to the payment of principal and all interest accrued, the holder shall receive a warrant to purchase
  1% of the number of common shares of the Company then outstanding at a price of $0.15 per share.</P>
  
  <P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>
  
  <P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0pt; text-align: justify">In further consideration of Medpac&#8217;s
  investment, the Company has agreed to enter into an exclusive Distribution Agreement for the Company&#8217;s BeastCare DTS TM
  and Now Cardio devices in Australia and certain other designated countries in Southeast Asia. The Distribution Agreement will
  have an initial term of five years and can be renewed for an additional five years provided that agreed upon sales targets are
  met.</P>
  
  <P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>
  
  <P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0pt; text-align: justify">The Company reserves the right to renegotiate
  the terms of its Agreement with MedPac if the balance of the initial $500,000 due in respect of its investment is not timely received.</P>
  
  <P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>
  
  <P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>
  
  <P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0pt; text-align: justify"><B>Item 7.01 Regulation FD Disclosure.</B></P>
  
  <P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>
  
  <P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0pt; text-align: justify">On March 9, 2015, we issued a press release
  announcing that we had closed the first tranche of a $2,000,000 agreement related to the distribution of DreastCare DTS with Medpac
  Asia Pacific PTY Ltd. of Australia.. A copy of the press release is filed as Exhibit 99.1.</P>
  
  <P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>
  
  <P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0pt; text-align: justify">&nbsp;The information in Exhibit 99.1
  shall not be deemed as &#8220;filed&#8221; for purposes of Section&nbsp;18 of the Exchange Act, or otherwise subject to the liability
  of such Section, nor shall it be deemed incorporated by reference in any filing by us under the Securities Act or the Exchange
  Act, regardless of any general incorporation language in such filing, unless expressly incorporated by specific reference in such
  filing.</P>
  
  <P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>
  
  <P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>
  
  <P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0pt; text-align: justify"><B>Item&nbsp;9.01</B> <B>Financial Statements and Exhibits.</B></P>
  
  
  <P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
      <TD STYLE="width: 3%; line-height: 115%"><B>(d)</B></TD>
      <TD STYLE="width: 97%; line-height: 115%"><B>Exhibits.</B></TD></TR>
  </TABLE>
  <P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: bottom">
      <TD STYLE="width: 8%; border-bottom: black 1.5pt solid"><P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"><B>Exhibit</B></P>
          <P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"><B>Number</B></P></TD>
      <TD STYLE="width: 5%; line-height: 115%">&nbsp;</TD>
      <TD STYLE="width: 87%; border-bottom: black 1.5pt solid; line-height: 115%"><B>Description</B></TD></TR>
  <TR>
      <TD STYLE="line-height: 115%">&nbsp;</TD>
      <TD COLSPAN="2" STYLE="line-height: 115%">&nbsp;</TD></TR>
  <TR>
      <TD STYLE="vertical-align: top; line-height: 115%">10.1</TD>
      <TD STYLE="vertical-align: bottom; line-height: 115%">&nbsp;</TD>
      <TD STYLE="vertical-align: top"><A HREF="ecgi8k031015ex10_1.htm">Regulation S Subscription Agreement and Investment Representation with MedPac Asia Pacific PTY Ltd.&nbsp;</A></P>
                                      <P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0pt; text-align: justify"></P></TD></TR>
  <TR>
      <TD STYLE="vertical-align: top; line-height: 115%">10.2</TD>
      <TD STYLE="vertical-align: bottom; line-height: 115%">&nbsp;</TD>
      <TD STYLE="vertical-align: top"><A HREF="ecgi8k031015ex10_2.htm">Form of 8% Convertible Promissory Note</A></TD></TR>
  <TR>
      <TD STYLE="vertical-align: top; line-height: 115%">10.3</TD>
      <TD STYLE="vertical-align: bottom; line-height: 115%">&nbsp;</TD>
      <TD STYLE="vertical-align: top"><A HREF="ecgi8k031015ex10_3.htm">Form of Warrant.</A></TD></TR>
  <TR>
      <TD STYLE="vertical-align: top; line-height: 115%">10.4</TD>
      <TD STYLE="vertical-align: bottom; line-height: 115%">&nbsp;</TD>
      <TD STYLE="vertical-align: top"><A HREF="ecgi8k031015ex10_4.htm">Summary of Distribution Agreement Terms</A></TD></TR>
  </TABLE>
  
  <P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
  
  <P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in">&nbsp;</P>
  
  <P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"></P>
  
  <!-- Field: Page; Sequence: 2 -->
      <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
      <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
      <!-- Field: /Page -->
  
  <P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">SIGNATURES</P>
  
  <P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
  
  <P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0pt; text-align: justify">Pursuant to the requirements of the Securities Exchange
  Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</P>
  
  <P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"></P>
  
  <P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"></P>
  
  <P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
      <TD STYLE="line-height: 115%">&nbsp;</TD>
      <TD COLSPAN="2" STYLE="line-height: 115%">EVENT CARDIO GROUP INC.</TD>
      <TD STYLE="line-height: 115%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="width: 52%; line-height: 115%">&nbsp;</TD>
      <TD STYLE="width: 2%; line-height: 115%">&nbsp;</TD>
      <TD STYLE="width: 35%; line-height: 115%">&nbsp;</TD>
      <TD STYLE="width: 11%; line-height: 115%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="line-height: 115%">Dated: March 10, 2015</TD>
      <TD STYLE="line-height: 115%">By:</TD>
      <TD STYLE="border-bottom: black 1.5pt solid; line-height: 115%">/s/&nbsp;John Bentivoglio</TD>
      <TD STYLE="line-height: 115%">&nbsp;</TD></TR>
  <TR>
      <TD STYLE="vertical-align: top; line-height: 115%">&nbsp;</TD>
      <TD STYLE="vertical-align: top; line-height: 115%">&nbsp;</TD>
      <TD STYLE="vertical-align: bottom; line-height: 115%">John Bentivoglio</TD>
      <TD STYLE="vertical-align: top; line-height: 115%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="line-height: 115%">&nbsp;</TD>
      <TD STYLE="line-height: 115%">&nbsp;</TD>
      <TD STYLE="line-height: 115%">Chief Executive Officer</TD>
      <TD STYLE="line-height: 115%">&nbsp;</TD></TR>
  </TABLE>
  <P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>
  
  <!-- Field: Page; Sequence: 3; Options: Last -->
      <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
      <!-- Field: /Page -->
  
  <P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"></P>
  
  <P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt">&nbsp;</P>
  
  
  </BODY>
  </HTML>
metadata_documents: [{"type": "8-K", "sequence": "1", "filename": "ecgi8k031015.htm", "secsgml_size_bytes": 17408}]
metadata_filer: {"company-data": {"conformed-name": "Event Cardio Group Inc.", "cik": "0001394130", "assigned-sic": "1000", "irs-number": "208051714", "state-of-incorporation": "NV", "fiscal-year-end": "0930"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-52518", "film-number": "15691360"}, "business-address": {"street1": "2798 THAMESGATE DR.", "city": "MISSISSAUGA", "state": "A6", "zip": "L4T 4E8", "phone": "289-407-4377"}, "mail-address": {"street1": "2798 THAMESGATE DR.", "city": "MISSISSAUGA", "state": "A6", "zip": "L4T 4E8"}, "former-company": [{"former-conformed-name": "Sunrise Holdings LTD", "date-changed": "20080404"}, {"former-conformed-name": "Sunrise Mining CORP", "date-changed": "20070322"}]}
text: SECURITIES
  AND EXCHANGE COMMISSION
  Washington, D.C. 20549
  FORM 8-K
  CURRENT REPORT
  Pursuant to Section 13 or 15(d)
  of the Securities Exchange Act of 1934
  Date of Report (date of earliest event
  reported):
  March 9, 2015
  EVENT
      CARDIO GROUP INC.
  (Exact name of registrant as specified
      in its charter)
  Nevada
  0-52518
  20-8051714
  (State or other jurisdiction of Incorporation)
  (Commission File Number)
  (I.R.S. Employer Identification No.)
  2798 Thamesgate Dr.
  Mississauga, Ontario, Canada
  L4T
      4E8
  Check the appropriate box below if the
  Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions
  (see General Instruction A.2. below):
  •
  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
  •
  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17   CFR
  240.14a-12)
  •
  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17
  CFR 240.14d-2(b))
  •
  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17
  CFR 240.13e-4(c))
  Item 3.02 Sale of Unregistered Securities.
  On March 5, 2015, the Company received
  $200,000 from Medpac Asia Pacific PTY Ltd. in respect of the initial $500,000 due pursuant to the Regulation S Subscription Agreement
  and Investment Representation received by the Company from Medpac. The Subscription Agreement provides for an investment of $500,000
  by MedPpac for which it is to receive an 8% Convertible Promissory Note in the principal amount of $500,000 (the "Note").
  Interest accrued on the Note is payable annually on January 31, commencing January 31, 2016. The principal amount of the Note,
  together with accrued interest is payable on January 31, 2018. The principal and any interest accrued and not paid in cash, is
  convertible into common shares of the Company at a conversion price of $0.15 per share. The Note may be prepaid at any time upon
  ten days notice to the Holder, except that if the Note is prepaid when the common stock of the Company is trading at less than
  $0.15 per share, in addition to the payment of principal and all interest accrued, the holder shall receive a warrant to purchase
  1% of the number of common shares of the Company then outstanding at a price of $0.15 per share.
  In further consideration of Medpac's
  investment, the Company has agreed to enter into an exclusive Distribution Agreement for the Company's BeastCare DTS TM
  and Now Cardio devices in Australia and certain other designated countries in Southeast Asia. The Distribution Agreement will
  have an initial term of five years and can be renewed for an additional five years provided that agreed upon sales targets are
  met.
  The Company reserves the right to renegotiate
  the terms of its Agreement with MedPac if the balance of the initial $500,000 due in respect of its investment is not timely received.
  Item 7.01 Regulation FD Disclosure.
  On March 9, 2015, we issued a press release
  announcing that we had closed the first tranche of a $2,000,000 agreement related to the distribution of DreastCare DTS with Medpac
  Asia Pacific PTY Ltd. of Australia.. A copy of the press release is filed as Exhibit 99.1.
  The information in Exhibit 99.1
  shall not be deemed as "filed" for purposes of Section 18 of the Exchange Act, or otherwise subject to the liability
  of such Section, nor shall it be deemed incorporated by reference in any filing by us under the Securities Act or the Exchange
  Act, regardless of any general incorporation language in such filing, unless expressly incorporated by specific reference in such
  filing.
  Item 9.01
  Financial Statements and Exhibits.
  (d)
  Exhibits.
  Exhibit
  Number
  Description
  10.1
  Regulation S Subscription Agreement and Investment Representation with MedPac Asia Pacific PTY Ltd.
  10.2
  Form of 8% Convertible Promissory Note
  10.3
  Form of Warrant.
  10.4
  Summary of Distribution Agreement Terms
  SIGNATURES
  Pursuant to the requirements of the Securities Exchange
  Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
  EVENT CARDIO GROUP INC.
  Dated: March 10, 2015
  By:
  /s/ John Bentivoglio
  John Bentivoglio
  Chief Executive Officer